Contenido principal del artículo

Laura Cristina Orbe Muñoz
Gabriele Davide Bigoni Ordóñez

La Diabetes del adulto de inicio juvenil, es un subtipo hereditario poco común que se manifiesta a una edad temprana, relacionado con mutaciones en genes específicos que principalmente afectan la función de las células beta pancreática. Un diagnóstico preciso es fundamental para un tratamiento efectivo, aunque puede ser desafiante debido a la variabilidad en sus características clínicas y moleculares. Esta revisión analiza la evidencia disponible sobre estas características y los métodos de diagnóstico utilizados en laboratorio. Se realizó una búsqueda exhaustiva en bases de datos científicas, seleccionando estudios relevantes según criterios específicos. Se analizaron características clínicas, hallazgos moleculares y métodos de diagnóstico, utilizando tablas, gráficos y síntesis narrativas. Se identificaron mutaciones genéticas asociadas con MODY, así como biomarcadores útiles en el laboratorio clínico. Además, se describieron métodos de diagnóstico molecular, incluyendo la secuenciación de próxima generación (NGS). Esta revisión resalta la importancia del diagnóstico preciso de MODY, subrayando la diversidad de sus características biológicas y moleculares, y la necesidad de una investigación más profunda para mejorar su identificación y manejo clínico.

Maturity Onset Diabetes of the Young is a rare hereditary subtype that manifests at an early age, related to mutations in specific genes that primarily affect the function of pancreatic beta cells. An accurate diagnosis is crucial for effective treatment, though it can be challenging due to variability in clinical and molecular characteristics. This review examines available evidence on these characteristics and laboratory diagnostic methods. A comprehensive search was conducted in scientific databases, selecting relevant studies based on specific criteria. Clinical features, molecular findings, and diagnostic methods were analyzed using tables, graphs, and narrative synthesis. Genetic mutations associated with MODY were identified, as well as useful biomarkers in clinical laboratory settings. Additionally, molecular diagnostic methods were described, including next-generation sequencing (NGS). This review emphasizes the importance of precise MODY diagnosis, highlighting the diversity of its biological and molecular characteristics, and the need for further research to enhance its identification and clinical management.

Descargas

Los datos de descargas todavía no están disponibles.

Detalles del artículo

Cómo citar
Orbe Muñoz, L. C., & Bigoni Ordóñez, G. D. (2024). Características de la Diabetes del adulto de inicio juvenil y su diagnóstico en el laboratorio. Revista Vive, 7(20), 554–570. https://doi.org/10.33996/revistavive.v7i20.322
Sección
ARTÍCULO DE REVISIÓN
Biografía del autor/a

Laura Cristina Orbe Muñoz, Universidad Católica de Cuenca. Cuenca, Ecuador

Licenciada en Laboratorio Clínico, Universidad de Cuenca. Estudiante de la Maestría en Diagnóstico
Clínico y Molecular, Universidad Católica de Cuenca. Pasantías en el Instituto del Cáncer Solca-Cuenca, Hospital Vicente Corral Moscoso-Cuenca. Actualmente trabajando en el Hospital Monte Sinaí-Cuenca, Ecuador

Gabriele Davide Bigoni Ordóñez, Universidad de Cuenca. Cuenca, Ecuador

Licenciado en Laboratorio Clínico, Universidad de Cuenca, Cuenca – Ecuador. Master en Ciencias Bioquímicas campo de conocimiento en Biología Molecular. Universidad Nacional Autónoma de México. Doctorado en Ciencias Bioquímicas campo de conocimiento en Biología Molecular. Universidad Nacional Autónoma de México. Docente-Investigador de la Carrera de Laboratorio Clínico de la Facultad de Ciencias Médicas, Universidad de Cuenca. Docente invitado de posgrado de la Universidad Católica de Cuenca, Ecuador.

Referencias

Rojas P, Molina R, Rodríguez C. Definición, clasificación y diagnóstico de la diabetes mellitus. Rev Venez Endocrinol Metab. 2012; 10:7-12. https://acortar.link/PAyTvx

Urakami T. Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment. Diabetes Metab Syndr Obes. 2019; 12:1047-56. https://acortar.link/LwOCV7

Eizirik D, Pasquali L, Cnop M. Pancreatic ?-cells in type 1 and type 2 diabetes mellitus: different pathways to failure. Nat Rev Endocrinol; 16(7):349-62. https://acortar.link/Vv9dnc

Ellard S, Bellanné-Chantelot C, Hattersley A. Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young. Diabetologia. 2008; 51(4):546-53. https://acortar.link/v2jIzW

Bobadilla-Olaje G, Calleja-López R, Ruibal-Tavares E, Rivera-Rosas C, Aguilera-Duarte L. Diabetes del adulto de inicio juvenil (diabetes tipo MODY). Rev Mex Pediatría. 2022; 89(1):27-31. https://acortar.link/OxZmxe

American Diabetes Association. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes. Diabetes Care. 2019; 43(Supplement_1): S14-31. https://acortar.link/YYZ3fb

Velho G, Robert J. Maturity-onset diabetes of the young (MODY): genetic and clinical characteristics. Horm Res. 2002; 57 Suppl 1:29-33. https://acortar.link/gnT3IZ

Carlsson A, Shepherd M, Ellard S, Weedon M, Lernmark Å, Forsander G, et al. Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study. Diabetes Care. 2020; 43(1):82-9. https://acortar.link/Oylojj

Shields B, McDonald T, Ellard S, Campbell M, Hyde C, Hattersley AT. The development and validation of a clinical prediction model to determine the probability of MODY in patients with young-onset diabetes. Diabetologia. 2012; 55(5):1265-72. https://acortar.link/XXYfRQ

Tosur M, Philipson L. Precision diabetes: Lessons learned from maturity?onset diabetes of the young (MODY). J Diabetes Investig. 2022; 13(9):1465-71. https://acortar.link/2ZHXPc

Johnson S, Ellis J, Leo P, Anderson L, Ganti U, Harris J, et al. Comprehensive genetic screening: The prevalence of maturity-onset diabetes of the young gene variants in a population-based childhood diabetes cohort. Pediatr Diabetes. 2019; 20(1):57-64. https://acortar.link/yOjumb

Aarthy R, Aston-Mourney K, Mikocka-Walus A, Radha V, Amutha A, Anjana R, et al. Clinical features, complications and treatment of rarer forms of maturity-onset diabetes of the young (MODY) - A review. J Diabetes Complications. 2021; 35(1):107640. https://acortar.link/5S4GkD

Pérez-Guisado J. Hidratos de carbono, metabolismo de la glucosa y cáncer. Endocrinol Nutr. 2006; 53(4):252-5. https://acortar.link/WXGB72

Chen L, Chen X, Huang X, Song B, Wang Y, Wang Y. Regulation of glucose and lipid metabolism in health and disease. Sci China Life Sci. 2019; 62(11):1420-58. https://acortar.link/K7c9sj

Aronoff S, Berkowitz K, Shreiner B, Want L. Glucose Metabolism and Regulation: Beyond Insulin and Glucagon. Diabetes Spectr. 2004; 17(3):183-90. https://acortar.link/RfhKkS

Castrejón V, Carbó R, Martínez M. Mecanismos moleculares que intervienen en el transporte de la glucosa. Rev Educ Bioquímica. 2007; 26(2):49-57. https://acortar.link/zMfM2R

Chadt A, Al-Hasani H. Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease. Pflüg Arch - Eur J Physiol. 2020; 472(9):1273-98. https://acortar.link/9743Pf

Reyes A, Plancarte A. Bases moleculares de las acciones de la insulina. Rev Educ Bioquímica. 2008; 27(1):9-18. https://acortar.link/JVUtzf

Conget I. Diagnóstico, clasificación y patogenia de la diabetes mellitus. Rev Esp Cardiol. 2002; 55(5):528-35. https://acortar.link/urtHgn

American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2010; 33(Supplement_1): S62-9. https://acortar.link/Jov3XB

Leslie R, Evans-Molina C, Freund-Brown J, Buzzetti R, Dabelea D, Gillespie K, et al. Adult-Onset Type 1 Diabetes: Current Understanding and Challenges. Diabetes Care. 2021; 44(11):2449-56. https://acortar.link/00mQPZ

Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe K, et al. Pathophysiology of Type 2 Diabetes Mellitus. Int J Mol Sci. 2020; 21(17):6275. https://acortar.link/2XC6NZ

Standards of Medical Care in Diabetes-2010. Diabetes Care. 2010; 33(Suppl 1): S11-61. https://acortar.link/fAV1IW

Rangel-Coronado R, Chávez-García T, Mendoza-Zubieta V, Ferreira-Hermosillo A. Diabetes del adulto de inicio juvenil: reporte de un caso. Rev Médica Inst Mex Seguro Soc. 2020; 57(4):252-8. https://acortar.link/hwDDBG

OPS. Diabetes - OPS/OMS | Organización Panamericana de la Salud. https://acortar.link/n4sYt4

Perfiles Carga Enfermedad Diabetes 2023 | OPS/OMS | Organización Panamericana de la Salud. https://acortar.link/dqynjO

Rosero M, Guerrero J. Compendio estadístico. Ecuador: Inec. 2015. https://acortar.link/OfY22y

ENSANUT-ECU. Encuesta Nacional de Salud y Nutrición 2012. Tomo 1 Ecuador 2012. 2014. https://acortar.link/pwLi7L

Pihoker C, Gilliam L, Ellard S, Dabelea D, Davis C, Dolan L, et al. Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth. J Clin Endocrinol Metab. 2013; 98(10):4055-62. https://acortar.link/1dzH0G

Hattersley A, Greeley A, Polak M, Rubio-Cabezas O, Njølstad P, Mlynarski W, et al. ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes. 2018; 19 Suppl 27:47-63. https://acortar.link/cHFJ2Y

Mohan V, Radha V, Nguyen T, Stawiski E, Pahuja K, Goldstein L, et al. Comprehensive genomic analysis identifies pathogenic variants in maturity-onset diabetes of the young (MODY) patients in South India. BMC Med Genet. 2018; 19(1):22. https://acortar.link/kkqxfx

Oliveira S, Neves J, Pérez A, Carvalho D. Maturity-onset diabetes of the young: From a molecular basis perspective toward the clinical phenotype and proper management. Endocrinol Diabetes Nutr. 2020; 67(2):137-47. https://acortar.link/nvjYNK

Fajans S, Bell G, Polonsky K. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med. 2001; 345(13):971-80. https://acortar.link/f97cO6

Nkonge K, Nkonge D, Nkonge T. The epidemiology, molecular pathogenesis, diagnosis, and treatment of maturity-onset diabetes of the young (MODY). Clin Diabetes Endocrinol. 2020; 6(1):20. https://acortar.link/8DofkT

Naylor R, Johnson A, Gaudio D del. Maturity-Onset Diabetes of the Young Overview. En: GeneReviews®. University of Washington, Seattle; 2018. https://acortar.link/T1OCfE

Yahaya T, Ufuoma S. Genetics and Pathophysiology of Maturity-onset Diabetes of the Young (MODY): A Review of Current Trends. Oman Med J. 2020; 35(3):e126. https://acortar.link/EWk0Rc

Horikawa Y, Enya M. Genetic Dissection and Clinical Features of MODY6 (NEUROD1-MODY). Curr Diab Rep. 2019; 19(3):12. https://acortar.link/sE31aq

Kleinberger J, Copeland K, Gandica R, Haymond M, Levitsky LL, Linder B, et al. Monogenic diabetes in overweight and obese youth diagnosed with type 2 diabetes: the TODAY clinical trial. Genet Med. 2018; 20(6):583-90. https://acortar.link/5S7SMW

Xiao X, Liu L, Xiao Y, Xie Z, Li L, Zhou H, et al. Novel frameshift mutation in the insulin (INS) gene in a family with maturity onset diabetes of the young (MODY). J Diabetes. 2019; 11(1):83-6. https://acortar.link/kWDXNj

Schober E, Rami B, Grabert M, Thon A, Kapellen T, Reinehr T, et al. Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database. Diabet Med J Br Diabet Assoc. 2009; 26(5):466-73. https://acortar.link/fFE3s1

Hoffman L, Fox T, Anastasopoulou C, Jialal I. Maturity Onset Diabetes in the Young. En: StatPearls. Treasure Island (FL): StatPearls Publishing; 2023. https://acortar.link/wH3Yq3

Delvecchio M, Pastore C, Giordano P. Treatment Options for MODY Patients: A Systematic Review of Literature. Diabetes Ther. 2020; 11(8):1667-85. https://acortar.link/C3Hu15

Broome D, Pantalone K, Kashyap S, Philipson L. Approach to the Patient with MODY-Monogenic Diabetes. J Clin Endocrinol Metab. 2020; 106(1):237-50. https://acortar.link/WVpxSj

Karaoglan M, Nacarkahya G. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis. J Diabetes. 2021; 13(2):154-63. https://acortar.link/f6gJtF

da Silva T, Fonseca L, Santos S, Borges D, Martins A, Couto de Carvalho A, et al. MODY probability calculator utility in individuals’ selection for genetic testing: Its accuracy and performance. Endocrinol Diabetes Metab. 2022; 5(5): e00332. https://acortar.link/2aCREz

Peixoto-Barbosa R, Reis AF, Giuffrida M. Update on clinical screening of maturity-onset diabetes of the young (MODY). Diabetol Metab Syndr. 2020; 12(1):50. https://acortar.link/7HFy79

Diren A, Demirci D, Gul N, Karacanli B, Baykut A, Tutuncu Y, et al. Cytokine Profile in Patients With Maturity-onset Diabetes of the Young (MODY). In Vivo. 2022; 36(5):2490-504. https://acortar.link/1HjOzk

Y?lmaz S, Sagsak E, Aycan Z. Urinary C-Peptide/Creatinine Ratio Can Distinguish Maturity-Onset Diabetes of the Young from Type 1 Diabetes in Children and Adolescents: A Single-Center Experience. Horm Res Paediatr. 2015; 84(1):54-61. https://acortar.link/4gHVUb

Viñoles J, Aure G, Camperos P, Casanova MIS dé. Heterogeneidad fenotípica en el diagnóstico de MODY. Una aproximación basada en la evidencia para el diagnóstico clínico. Rev Científica CMDLT. 2020; 14(2). https://acortar.link/GgpU7j

Christoffersen C. Apolipoprotein M-A Marker or an Active Player in Type II Diabetes? Front Endocrinol. 2021; 12. https://acortar.link/S5UtLo

Nowak N, Szopa M, Thanabalasingham G, McDonald TJ, Colclough K, Skupien J, et al. Cystatin C is not a good candidate biomarker for HNF1A-MODY. Acta Diabetol. 2013; 50(5):815-20. https://acortar.link/yKY4Co

Sagar R, Phoenix F, Thanabalasingham G, Naseem K, Ajjan R, Owen K. Maturity onset diabetes of the young and fibrin-related thrombosis risk. Diab Vasc Dis Res [Internet]. 2020 [citado 18 de diciembre de 2023];17(6):1479164120963048. Disponible en: https://doi.org/10.1177/1479164120963048

Firdous P, Nissar K, Masoodi S, Ganai B. Biomarkers: Tools for Discriminating MODY from Other Diabetic Subtypes. Indian J Endocrinol Metab. 2022; 26(3):223. https://acortar.link/QRj4yQ

Al-Kandari H, Al-Abdulrazzaq D, Davidsson L, Nizam R, Jacob S, Melhem M, et al. Identification of Maturity-Onset-Diabetes of the Young (MODY) mutations in a country where diabetes is endemic. Sci Rep. 2021; 11(1):16060. https://acortar.link/H8x3nu

de Santana L, Caetano L, Costa-Riquetto A, Franco P, Dotto R, Reis A, et al. Targeted sequencing identifies novel variants in common and rare MODY genes. Mol Genet Genomic Med. 2019; 7(12): e962. https://acortar.link/JS8e19

Park S, Jang S, Ahn CH, Kim J, Jung H, Cho Y, et al. Identifying Pathogenic Variants of Monogenic Diabetes Using Targeted Panel Sequencing in an East Asian Population. J Clin Endocrinol Metab. 2019; 104(9):4188-98. https://acortar.link/ItSO1n

Jang K. Maturity-onset diabetes of the young: update and perspectives on diagnosis and treatment. Yeungnam Univ J Med. 2020; 37(1):13-21. https://acortar.link/CVLFpW

Hulín J, Škopková M, Valkovi?ová T, Mikulajová S, Roso?anková M, Papcun P, et al. Clinical Implications of the Glucokinase Impaired Function – GCK-MODY Today. Physiol Res. 2020; 69(6):995-1011. https://acortar.link/Y6HA8M

Stanik J, Skopkova M, Stanikova D, Brennerova K, Barak L, Ticha L, et al. Neonatal hypoglycemia, early-onset diabetes and hypopituitarism due to the mutation in EIF2S3 gene causing MEHMO syndrome. Physiol Res. 2018; 67(2):331-7. https://acortar.link/NbSJAE